Dudediligence.

Aptevo Therapeutics Inc

APVONASDAQ · Pharmaceutical Preparations
Write an idea

Fundamentals

Oldest to newest
Net income, by quarter
−$5.1MSep ’24−$6.3MDec ’24−$6.4MMar ’25−$6.2MJun ’25−$7.5MSep ’25−$5.8MDec ’25−$6.7MMar ’26−$6.4MJun ’26
Fiscal years, by the month each ended
LineDec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue$12.3M$3.1Mnone on filenone on filenone on file
Operating income−$21.4M−$28.6M−$28.9M−$24.6M−$26.3M
Net income−$28.5M$8.0M−$17.4M−$24.1M−$26.0M
Operating cash flow−$21.7M−$21.0M−$11.7M−$23.8M−$25.6M
Free cash flow−$22.4M−$21.1Mnone on filenone on filenone on file
Cash$45.0M$22.6M$16.9M$8.7M$21.6M
Debt$15.4M$3.5Mnone on filenone on filenone on file
Shares outstanding4.9M6.5M12.0K4.1K997.8K